Antares Pharma buy melinda
Start price
08.10.17
/
50%
€3.58
Target price
19.12.17
€3.79
Performance (%)
-48.24%
End price
19.12.17
€1.85
Summary
This prediction ended on 19.12.17 with a price of €1.85. The BUY prediction by melinda for Antares Pharma performed very badly with a performance of -48.24%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Antares Pharma | - | - | - | - |
| iShares Core DAX® | -2.680% | 4.261% | 2.121% | 57.510% |
| iShares Nasdaq 100 | 0.725% | 5.796% | 34.204% | 92.829% |
| iShares Nikkei 225® | -0.725% | 9.319% | 61.298% | 80.340% |
| iShares S&P 500 | 1.166% | 5.479% | 24.751% | 70.967% |
Comments by melinda for this prediction
In the thread Antares Pharma diskutieren
pharma
Kaution ANDS angekündigt 17. April 2017. PDUFA Datum 17. Oktober 2017 eine vorrangige Prüfung von 6 Monaten angenommen.
(Vom Mitglied beendet)